These words uttered in 1901 relate directly to studies of thrombolytics for AMI. In GISSI-1 and 2 other major thrombolysis trials, the investigators did not require an informed consent of the patients ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...
Patients with stroke due to blood clots in brain arteries ('ischaemic stroke') can be treated with clot-dissolving drugs called 'thrombolytics'. By dissolving blood clots, thrombolytic drugs improve ...
CAMBRIDGE, Mass., Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue ...
Stroke patients who can't get to the hospital quickly enough to be eligible for the usual clot-busting treatments may soon ...
Making the switch from alteplase to tenecteplase for stroke thrombolysis can be done successfully when the appropriate preparations are taken, and it may improve patient outcomes, the experience of a ...
HSINCHU, Taiwan--(BUSINESS WIRE)--As COVID-19 vaccination has raised the issue of thrombosis, Dr. Chih-Kuang Yeh, Distinguished Professor of the Department of Biomedical Engineering and Environmental ...
Mary Pietruziewicz was enjoying a cocktail with her husband when her speech became garbled. Concerned, he rushed her to Northwestern Medicine Delnor Hospital's Emergency Department where a CT scan ...
The proof of efficacy of thrombolysis for acute myocardial infarction (AMI) depends on 9 randomized placebo-controlled trials totaling 58,511 patients. The meta-analysis of these trials showed an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback